Cargando…

Real‐life second‐line epirubicin–paclitaxel regimen as treatment of relapsed small‐cell lung cancer: EpiTax study

BACKGROUND: Few therapeutic options are approved as second‐line treatment after failure of platinum‐based chemotherapy for patients with extensive‐stage small‐cell lung cancer (ES‐SCLC). Topotecan widespread use remains challenged by the risk of severe toxicities in a pretreated population. Little i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Annic, Josselin, Babey, Hélène, Corre, Romain, Descourt, Renaud, Quéré, Gilles, Renaud, Emmanuelle, Lambert, Mickaël, Le Noac'h, Pierre, Dhamelincourt, Estelle, Nguyen, Jessica, Vu, Alicia, Bourbonne, Vincent, Robinet, Gilles, Geier, Margaux
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939142/ https://www.ncbi.nlm.nih.gov/pubmed/36000584 http://dx.doi.org/10.1002/cam4.5143

Ejemplares similares

Pembrolizumab plus pemetrexed-carboplatin combination in first-line treatment of advanced non-squamous non-small cell lung cancer: a multicenter real-life study (CAP29)
por: Renaud, Emmanuelle, et al.
Publicado: (2023)

Vascular Acrosyndromes Associated With Prolonged Tumor Response in Advanced Lung Cancer Patients During Treatment With Antimetabolites: A Report of Two Cases
por: Geier, Margaux, et al.
Publicado: (2021)

Duration of nivolumab for pretreated, advanced non–small‐cell lung cancer
por: Geier, Margaux, et al.
Publicado: (2020)

Henoch–Schönlein Purpura Associated with Lung Cancer: When Paraneoplastic Manifestations Impede Oncological Management
por: Philippe, Éloïse, et al.
Publicado: (2021)

First‐line pembrolizumab for non–small cell lung cancer patients with PD‐L1 ≥50% in a multicenter real‐life cohort: The PEMBREIZH study
por: Amrane, Karim, et al.
Publicado: (2020)

Durvalumab‐induced lesions of bronchiolitis and fully reversible bronchiectasis in a patient with non‐small cell lung cancer: A case report
por: Domblides, Maël, et al.
Publicado: (2021)

Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-small-cell lung cancer
por: Quéré, Gilles, et al.
Publicado: (2016)

Case Report: Coronaro-bronchial fistula vascularizing a squamous cell lung cancer
por: Ntshaykolo, Chloe, et al.
Publicado: (2023)

The abscopal effect of immune-radiation therapy in recurrent and metastatic cervical cancer: a narrative review
por: Ollivier, Luc, et al.
Publicado: (2023)

Multi-Omics Approaches for the Prediction of Clinical Endpoints after Immunotherapy in Non-Small Cell Lung Cancer: A Comprehensive Review
por: Bourbonne, Vincent, et al.
Publicado: (2022)

Narrative Review of Synergistics Effects of Combining Immunotherapy and Stereotactic Radiation Therapy
por: Lucia, François, et al.
Publicado: (2022)

Brief Report on the Efficacy of Nivolumab in Patients With Previously Treated Advanced Large-Cell Neuroendocrine Cancer of the Lung
por: Agar, Camille, et al.
Publicado: (2020)

Effects of Vertical Spatial Overlap on Phytoplankton Diversity under Experimentally Altered Lake Stratification Regimes
por: Le Noac’h, Philippe, et al.
Publicado: (2021)

A Quantitative Investigation of Mental Fatigue Elicited during Motor Imagery Practice: Selective Effects on Maximal Force Performance and Imagery Ability
por: Di Rienzo, Franck, et al.
Publicado: (2023)

Toxicity after volumetric modulated arc therapy for lung cancer: a monocentric retrospective study
por: Bourbonne, Vincent, et al.
Publicado: (2021)

Focus on treatment of lung carcinoid tumor
por: Noel-Savina, Elise, et al.
Publicado: (2013)

APH-2 and Tax expression are correlated with a HTLV-2 proviral load but not with lymphocytosis
por: Douceron, Estelle, et al.
Publicado: (2011)

Epirubicin
por: Cornish, J., et al.
Publicado: (1988)

The Transcription Profile of Tax-3 Is More Similar to Tax-1 than Tax-2: Insights into HTLV-3 Potential Leukemogenic Properties
por: Chevalier, Sébastien A., et al.
Publicado: (2012)

HTLV-1 Tax targets centrosomal Cep63 protein
por: Martin, Emilie, et al.
Publicado: (2015)

Taxing capital and labor when both factors are imperfectly mobile internationally
por: d’Albis, Hippolyte, et al.
Publicado: (2021)

Lung Cancer in an Orthoprosthetist Using Vermiculite
por: Durand-Moreau, Quentin, et al.
Publicado: (2017)

Predominant role of Tax sumoylation in Tax-induced NF-kB activation in T cells
por: Bonnet, Amandine, et al.
Publicado: (2011)

Study on the infusion-site adverse events and vascular distribution of epirubicin in chemotherapy with epirubicin and fosaprepitant
por: Yamasaki, Miho, et al.
Publicado: (2019)

False Positive 18F-FDG Positron Emission Tomography Findings in Schwannoma—A Caution for Reporting Physicians
por: Boré, Paul, et al.
Publicado: (2018)

EpiBasket: how e-commerce tools can improve epidemiological preparedness
por: Xing, Weijia, et al.
Publicado: (2013)

Low levels of HTLV-2 Tax conjugation to ubiquitin and SUMO do not impede Tax-mediated activation of NF-κB
por: Journo, Chloé, et al.
Publicado: (2014)

Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small-Cell Lung Cancers: Long-Term Follow-Up and Focus on Post-Brigatinib Lorlatinib Efficacy in the Multicenter, Real-World BrigALK2 Study
por: Descourt, Renaud, et al.
Publicado: (2022)

Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study)
por: Corre, Romain, et al.
Publicado: (2018)

Epirubicin-induced Kounis syndrome
por: Liang, Hui-zhu, et al.
Publicado: (2021)

TRAF5-mediated Tax ubiquitination modulates IKK phosphorylation but not binding to NEMO
por: Bonnet, Amandine, et al.
Publicado: (2014)

SQSTM1/p62 regulates HTLV-1 tax mediated NF-κB activation
por: Schwob, Aurélien, et al.
Publicado: (2015)

Presence of a functional but dispensable Nuclear Export Signal in the HTLV-2 Tax protein
por: Chevalier, Sébastien A, et al.
Publicado: (2005)

Tax Risks and Tax Planning
por: Boldycheva, A. G., et al.
Publicado: (2022)

Morphometrics as an Insight Into Processes Beyond Tooth Shape Variation in a Bank Vole Population
por: Ledevin, Ronan, et al.
Publicado: (2010)

Molecular Mechanisms of Resistance to Tumour Anti-Angiogenic Strategies
por: Grépin, Renaud, et al.
Publicado: (2010)

NRP/Optineurin Cooperates with TAX1BP1 to Potentiate the Activation of NF-κB by Human T-Lymphotropic Virus Type 1 Tax Protein
por: Journo, Chloé, et al.
Publicado: (2009)

Randomised trial of epirubicin alone versus 5-fluorouracil, epirubicin and mitomycin C in locally advanced and metastatic carcinoma of the pancreas.
por: Topham, C., et al.
Publicado: (1991)

Environmental taxes and green tax reform.
Publicado: (1997)

Tax Insight: For Tax Year 2012
por: Murdock, M
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_t9bq2i73svo9bsbofaa6akfp6m